Ioanna Giopanou

7PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 29, 2023
Non-Oncogene Addiction of KRAS-Mutant Cancers to IL-1β via Versican and Mononuclear IKKβ.

Magda Spella, Giannoula Ntaliarda, Georgios Skiadas

|Aug 07, 2019
Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight.

Anne-Sophie Lamort, Ioanna Giopanou, Ioannis Psallidas

|May 31, 2019
Interleukin-1β provided by KIT-competent mast cells is required for KRAS-mutant lung adenocarcinoma.

Ioannis Lilis, Giannoula Ntaliarda, Vassilios Papaleonidopoulos

|Mar 31, 2019
Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma.

Dimitra Kerdidani, Panagiotis Chouvardas, Ares Rocanin Arjo

|Mar 29, 2018
IκB Kinase α Is Required for Development and Progression of KRAS-Mutant Lung Adenocarcinoma.

Malamati Vreka, Ioannis Lilis, Maria Papageorgopoulou

|Feb 16, 2017
Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis.

Ioanna Giopanou, Ioannis Lilis, Vassilios Papaleonidopoulos

Pageof 2